한빛사논문
Hong-Gyun Lee 1, Joseph M. Rone 1, Zhaorong Li 1,2, Camilo Faust Akl 1, Seung Won Shin 3, Joon-Hyuk Lee 1, Lucas E. Flausino 1, Florian Pernin 4, Chun-Cheih Chao 1, Kilian L. Kleemann 5, Lena Srun 1, Tomer Illouz 1, Federico Giovannoni 1, Marc Charabati 1, Liliana M. Sanmarco 1, Jessica E. Kenison 1, Gavin Piester 1,6, Stephanie E. J. Zandee 7, Jack P. Antel 4, Veit Rothhammer 1,8, Michael A. Wheeler 1,2, Alexandre Prat 7, Iain C. Clark 3 & Francisco J. Quintana 1,2,9 ,*
1Ann Romney Center for Neurologic Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA.
2Broad Institute of MIT and Harvard, Cambridge, MA, USA.
3Department of Bioengineering, College of Engineering, California Institute for Quantitative Biosciences, QB3, University of California Berkeley, Berkeley, CA, USA.
4Neuroimmunology Unit, Montreal Neurological Institute, Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.
5School of Computing, University of Portsmouth, Portsmouth, UK.
6Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
7Neuroimmunology Research Lab, Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
8Department of Neurology, University Hospital, Friedrich-Alexander University Erlangen Nuremberg, Erlangen, Germany.
9Gene Lay Institute of Immunology and Inflammation, Boston, MA, USA.
*Corresponding author: correspondence to Francisco J. Quintana
Abstract
Disease-associated astrocyte subsets contribute to the pathology of neurologic diseases, including multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), an experimental model for multiple sclerosis. However, little is known about the stability of these astrocyte subsets and their ability to integrate past stimulation events. Here we report the identification of an epigenetically controlled memory astrocyte subset that exhibits exacerbated pro-inflammatory responses upon rechallenge. Specifically, using a combination of single-cell RNA sequencing, assay for transposase-accessible chromatin with sequencing, chromatin immunoprecipitation with sequencing, focused interrogation of cells by nucleic acid detection and sequencing, and cell-specific in vivo CRISPR–Cas9-based genetic perturbation studies we established that astrocyte memory is controlled by the metabolic enzyme ATP-citrate lyase (ACLY), which produces acetyl coenzyme A (acetyl-CoA) that is used by histone acetyltransferase p300 to control chromatin accessibility. The number of ACLY+p300+ memory astrocytes is increased in acute and chronic EAE models, and their genetic inactivation ameliorated EAE. We also detected the pro-inflammatory memory phenotype in human astrocytes in vitro; single-cell RNA sequencing and immunohistochemistry studies detected increased numbers of ACLY+p300+ astrocytes in chronic multiple sclerosis lesions. In summary, these studies define an epigenetically controlled memory astrocyte subset that promotes CNS pathology in EAE and, potentially, multiple sclerosis. These findings may guide novel therapeutic approaches for multiple sclerosis and other neurologic diseases.
논문정보
관련 링크
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기